Ryman Healthcare Limited (NZE:RYM)

Ryman Healthcare Balance Sheet

Financials in millions NZD. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	9.7	17.66	41.81	27.88	28.31
Trading Asset Securities	10.59	1.39	16.8	36.47	19.57
Cash & Short-Term Investments	20.29	19.04	58.61	64.35	47.88
Cash Growth	6.53%	-67.51%	-8.93%	34.40%	137.38%
Accounts Receivable	24.96	22.1	21.68	719.12	654.77
Other Receivables	3.18	5.51	18.09	-	16.69
Receivables	28.14	27.61	39.77	719.12	671.46
Inventory	0.01	0.01	2.39	14.62	26.31
Prepaid Expenses	23.2	25.52	17.86	-	-
Other Current Assets	155.93	145.23	207.55	45.6	15.42
Total Current Assets	227.57	217.41	326.17	843.69	761.07
Property, Plant & Equipment	1,099	1,020	1,135	2,205	2,091
Other Intangible Assets	10.04	13.82	40.73	84.83	51.68
Long-Term Deferred Tax Assets	-	-	259.58	53.77	35.06
Other Long-Term Assets	10,930	10,736	10,142	9,323	8,027
Total Assets	12,266	11,986	11,904	12,511	10,966

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	72.2	94.59	145.32	180.13	78.95
Accrued Expenses	72.56	80.24	76.29	49.77	39.81
Current Portion of Long-Term Debt	-	-	-	117.6	-
Current Portion of Leases	3	3.62	5.42	5.2	7.6
Other Current Liabilities	6,187	5,733	5,213	5,152	911.94
Total Current Liabilities	6,334	5,911	5,440	5,505	1,038
Long-Term Debt	1,588	1,698	2,559	2,219	2,604
Long-Term Leases	7.86	9.09	16.7	8.59	5.89
Long-Term Unearned Revenue	258.53	184.02	140.86	99.27	81.25
Long-Term Deferred Tax Liabilities	-	-	-	14.68	42.48
Other Long-Term Liabilities	-	-	-	-	3,760
Total Liabilities	8,189	7,802	8,157	7,847	7,532

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	1,923	1,923	952.89	953.24	33.29
Retained Earnings	1,977	2,152	2,678	3,111	2,966
Treasury Stock	-12.11	-16.28	-34.73	-34.73	-38.17
Comprehensive Income & Other	189.58	125.68	150.62	634.16	473.21
Shareholders' Equity	4,078	4,184	3,746	4,664	3,435
Total Liabilities & Equity	12,266	11,986	11,904	12,511	10,966

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	1,599	1,711	2,581	2,351	2,618
Net Cash (Debt)	-1,578	-1,692	-2,523	-2,286	-2,570
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-1.55	-2.38	-3.67	-4.43	-5.14
Filing Date Shares Outstanding	1,015	1,015	685.15	685.15	497.26
Total Common Shares Outstanding	1,015	1,015	685.15	685.15	497.26
Working Capital	-6,107	-5,694	-5,114	-4,661	-277.22
Book Value Per Share	4.02	4.12	5.47	6.81	6.91
Tangible Book Value	4,068	4,170	3,706	4,579	3,383
Tangible Book Value Per Share	4.01	4.11	5.41	6.68	6.80
Land	161.35	157.17	262.95	772.34	565.32
Buildings	865.54	748.46	552.91	594.66	502.91
Machinery	256.57	254.1	245.02	220.59	223.65
Construction In Progress	0.27	30.76	212.82	747.88	922.35

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 27, 2026

Data Sources Report a data error